George Golumbeski
CIK 1586660 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$353.9K
Companies
6
Total Filings
40
Lifetime Open-Market Net
-$1.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABOS | Director | 35,500 | $2.37 | $84.1K | $0 | 2 | 2026-06-05 |
| STTK | Director | 54,613 | $4.94 | $269.8K | $199.8K | 9 | 2026-06-02 |
| MURAV | Director | — | — | — | $0 | 3 | 2025-12-05 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | 0 | $8.68 | $0 | $251.6K | 16 | 2025-07-31 |
| CRBP | Director | — | $8.19 | — | $0 | 1 | 2020-07-08 |
| ENTA | Director | 0 | $11.90 | $0 | -$2.18M | 9 | 2020-02-28 |
Recent Filings · Page 3 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-26 | STTK | Buy (P) | +26,283 | $97.0K | EDGAR |
| 2022-01-05 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | STTK | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-28 | STTK | Grant (A) | — | $0 | EDGAR |
| 2020-07-08 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-28 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2020-01-07 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.